XTX Topco’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

XTX Topco’s Portfolio CTIC Stock Details CTIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-23,073	Closed	-$96.9K	–	1995
2023 Q1	$96.9K	Buy	+23,073	New	+$120K	0.02%	1102
2022 Q3	–	Sell	-14,669	Closed	-$88K	–	1506
2022 Q2	$88K	Buy	+14,669	New	+$75.1K	0.04%	677

Other funds holding CTIC

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

XTX Topco's CTIC Position: Q2 2023 in Review

XTX Topco sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 23,073 shares — an estimated $96.9K sold.

XTX Topco first reported a position in CTIC in Q2 2022 and held it in 2 quarters. The position peaked at $96.9K in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.

XTX Topco reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
XTX Topco sold 23,073 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $96.9K.
XTX Topco first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2022 and held it in 2 quarters.
XTX Topco's CTI BioPharma Corp. (DE) Common Stock position peaked at $96.9K in Q1 2023.
2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.

Based on XTX Topco's 13F filing for Q2 2023, filed 14 Aug 2023.